# Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients

> **NCT01265615** · PHASE4 · COMPLETED · sponsor: **Ural State Medical University** · enrollment: 109 (actual)

## Conditions studied

- Cardiorenal Syndrome
- Chronic Allograft Nephropathy

## Interventions

- **DRUG:** Paricalcitol
- **DRUG:** Calcitriol
- **DRUG:** Cholecalciferol
- **DIETARY_SUPPLEMENT:** Supplemental

## Key facts

- **NCT ID:** NCT01265615
- **Lead sponsor:** Ural State Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-04
- **Final completion:** 2010-09
- **Target enrollment:** 109 (ACTUAL)
- **Last updated:** 2015-06-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01265615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01265615, "Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01265615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*